Your fitbit could warn doctors of dangerous side effects
NCT ID NCT03971266
Summary
This study tested if data from fitness trackers (like Fitbits) could provide a better, more objective way to measure how well cancer patients are functioning. Researchers wanted to see if this data could predict which patients in early-stage drug trials were most likely to experience serious side effects or need to stop treatment early. Participants wore a tracker and reported symptoms via a smartphone app for up to six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles County-USC Medical Center
Los Angeles, California, 90033, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.